Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,991.5
-25.6 (-0.85%)

 

  • STI Straits Times Index
    2,991.5
    -25.6 (-0.85%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,596.7
    1.9 (0.12%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,447.8
    -479.9 (-1.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,606.8
    -14.5 (-0.40%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,631.5
    -125.4 (-0.44%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,307.1
    -106.8 (-1.66%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,759.8M
  • Value: 1,503.9M
  • Rise: 161
  • Fall: 202
  • Unch: 414

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.112+0.004
Oceanus^0.050+0.003
ETC Singapore0.063+0.011
P5 Capital0.041+0.005
The Place Hldg0.102+0.016
Tritech0.021+0.004
Artivision Tech0.011-
Anchor Resources0.011+0.003
Sembcorp Marine0.164-0.003
MarcoPolo Marine0.022+0.001

World Indices

World Indices
Name Last Change
Nasdaq 13,530.9 +73.7
HSI 29,447.8 -479.9
HSCEI 11,677.5 -212.0
Jakarta 6,307.1 -106.8
Nikkei 225 28,631.5 -125.4
SSE Comp 3,606.8 -14.5
Shanghai A 3,780.7 -15.2
Shanghai B 249.5 -1.6
KOSPI 3,140.6 -20.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS CELYAD ONCOLOGY S.A. SPONSORED ADR
Updated on 21 Jan 2021 (End of trading day)
Last (USD): 8.480 Change: -0.100 High: 8.800 Remarks: -
Change (%): -1.17 Low: 8.440
Open 8.700 Yesterday's Close 8.58
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 22,850 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.25596 Trailing EPS (USD) e -2.27629 NAV (USD) b 2.3971
PE a - Trailing PE f - Price / NAV b 3.5376
Dividend (USD) d - Cash In Hand (USD) g 2.1104 Issued & Paid-up Shares c 14,205,200
Dividend Yield (%) d - Price / Cash In Hand g 4.018 Treasury Shares h -
Market Cap (M) 120.460 Enterprise Value (M) 94.641
Piotroski F Score 0 Exchange Code CYAD Par Value ( $ ) n.a.
52 Weeks Volatility (%) 79.67 Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 Jan 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Sep 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS NASDAQ 120.460 - - 3.5376 -
Industry Biotechnology NASDAQ 3,198.076 508.958 - 7.6919 0.531
Local Peer AMGEN INC NASDAQ 146,724.053 18.710 19.957 13.3885 2.338
Local Peer GILEAD SCIENCES INC NASDAQ 83,961.439 15.589 66.216 4.8129 3.800
Local Peer VERTEX PHARMACEUTICAL NASDAQ 62,055.468 52.732 23.063 7.6296 -
Local Peer ILLUMINA INC NASDAQ 59,111.020 58.993 92.651 12.5768 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 57,138.913 27.006 18.105 5.6431 -
Local Peer MODERNA INC NASDAQ 52,621.516 - - 19.0671 -
Local Peer BIOGEN INC NASDAQ 41,566.606 7.059 8.179 3.8636 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 34,527.297 14.361 36.094 3.1176 -
Local Peer SEAGEN INC NASDAQ 33,497.249 - 70.908 14.8347 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 32,553.740 - - 7.5927 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 25,110.579 - - 23.0826 -
Local Peer EXACT SCIENCES CORP NASDAQ 23,547.572 - - 10.0755 -
Other Local Peers INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), BIO-TECHNE CORP (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), FATE THERAPEUTICS (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), SEER INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARVINAS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), INSMED INC (NASDAQ), FIBROGEN INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), VERACYTE INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), XENCOR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), PERSONALIS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), VIELA BIO INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NANTKWEST INC (NASDAQ), REGENXBIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), UNIQURE N.V. (NASDAQ), PRECIGEN INC (NASDAQ), NKARTA INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), BIOATLA INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ALECTOR INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MACROGENICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), INHIBRX INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), VAXCYTE INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), PASSAGE BIO INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), HUMANIGEN INC (NASDAQ), CURIS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), CORTEXYME INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), KADMON HLDGS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), AFFIMED N V (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), VANDA PHARMACE INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AGENUS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), ARDELYX INC (NASDAQ), AVROBIO INC (NASDAQ), ONCORUS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AKOUOS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ATRECA INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), CHIMERIX INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), GERON CORP (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), BIOVIE INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), XBIOTECH INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), XOMA CORP (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), ATHERSYS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), NEXTCURE INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), INMUNE BIO INC (NASDAQ), TREVENA INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CABALETTA BIO INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), KAMADA LTD (NASDAQ), BELLUS HEALTH INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), MEDICINOVA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), IMV INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), METACRINE INC (NASDAQ), OTONOMY INC (NASDAQ), CHIASMA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), EVOGENE LTD (NASDAQ), SESEN BIO INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), IMMUNOME INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), INFLARX N V (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), SYNLOGIC INC (NASDAQ), ORGENESIS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), SAVARA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), COHBAR INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ADVAXIS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), VACCINEX INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), SOLIGENIX INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), PRECIPIO INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ATYR PHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), HISTOGEN INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), GEOVAX LABS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ)
Global Peer WUXI BIO HKEx 496,227.383 431.657 344.624 33.2192 -
Global Peer BEIGENE HKEx 264,357.580 - - 7.9558 -
Global Peer SINO BIOPHARM HKEx 150,134.387 48.915 58.668 4.1656 0.668
Global Peer ZAI LAB-SB HKEx 123,057.832 - - 34.1110 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,833.081 107.029 35.012 4.6609 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 21,501.689 - - 2.9408 -
Global Peer ARCUS BIOSCIENCES INC NYSE 2,405.408 - - 4.4183 -
Global Peer 3SBIO HKEx 19,382.232 17.554 12.908 1.6570 -
Global Peer VIVA BIOTECH HKEx 15,745.795 52.230 - 7.5689 0.198
Other Global Peers JACOBIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), ALPHAMAB-B (HKEx), JW THERAP-B (HKEx), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), HAOHAI BIOTEC (HKEx), JHBP-B (HKEx), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), SQZ BIOTECHNOLOGIES CO (NYSE), SINOMAB BIO-B (HKEx), KINTOR PHARMA-B (HKEx), DPHARMA (Bursa), OPTHEA LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), IMUGENE LIMITED (ASX), ESSEX BIO-TECH (HKEx), 22ND CENTURY GROUP INC (NYSE American), NANOVIRICIDES INC (NYSE American), IMMUTEP LTD (ASX), NEXT SCIENCE LTD (ASX), ANTEOTECH LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), IBIO INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), BIONOMICS LTD (ASX), UNI-BIO GROUP (HKEx), LEAF RESOURCES LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), MEMPHASYS LTD (ASX), REGENT PACIFIC (HKEx), GENETIC TECHNOLOGIES (ASX), ORAGENICS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), CT ENTERPRISE (HKEx), BIOTRON (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), Suntar Eco-City (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), REGENEUS LTD (ASX), ADALTA LTD (ASX), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), NANOLLOSE LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CRYOSITE (ASX), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.115
+1.37 %
10 Days -+0.310
+3.79 %
20 Days -+0.750
+9.70 %
Medium Term Return 3 Months -+0.410
+5.08 %
6 Months --1.745
-17.07 %
1 Year --2.620
-23.60 %
Long Term Return 2 Years --13.920
-62.14 %
3 Years --37.320
-81.48 %
5 Years --26.630
-75.85 %
Annualised Return Annualised --
-24.74 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 4.100 - 13.010 Change From 1 Year Low +4.380 % Change From 1 Year Low (%) +106.83
Change From 1 Year High -4.530 % Change From 1 Year High (%) -34.82
2 Years Range 4.100 - 23.200 Change From 2 Years Low +4.380 % Change From 2 Years Low (%) +106.83
Change From 2 Years High -14.720 % Change From 2 Years High (%) -63.45
5 Years Range 4.100 - 64.750 Change From 5 Years Low +4.380 % Change From 5 Years Low (%) +106.83
Change From 5 Years High -56.270 % Change From 5 Years High (%) -86.90
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Celyad Oncology SA engages in the development of cell-based therapies for the treatment of cancer. It operates through the following segments: Cardiology, Immuno-oncology, and Corporate. The Cardiology segment includes the company's Cardiopoiesis, Corquest, and C-Cathez platforms. The Immuno-oncology segment consists of all assets developed based on the CAR-T cell platform. The company was founded by Michel Lussier, William Wijns, and Christian Homsy on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.

Historical Price Data

Date Open High Low Close Volume VWAP
21 Jan 2021 8.700 8.800 8.440 8.480 22,850 -
20 Jan 2021 8.810 8.810 8.420 8.580 35,269 -
19 Jan 2021 8.970 9.000 8.400 8.750 82,460 -
15 Jan 2021 8.590 8.590 8.300 8.365 10,192 -
14 Jan 2021 8.410 8.440 8.280 8.440 11,224 -
13 Jan 2021 8.330 8.330 7.940 8.030 22,605 -
12 Jan 2021 8.339 8.620 8.339 8.522 8,748 -
11 Jan 2021 8.140 8.236 8.140 8.142 898 -
08 Jan 2021 8.700 8.700 8.100 8.170 9,673 -
07 Jan 2021 9.010 9.262 8.110 8.540 16,427 -
06 Jan 2021 8.450 8.590 8.450 8.590 3,890 -
05 Jan 2021 8.300 8.300 7.980 8.210 2,900 -
04 Jan 2021 8.160 8.170 8.100 8.130 6,621 -
31 Dec 2020 8.250 8.250 7.500 7.800 29,862 -
30 Dec 2020 8.040 8.160 7.876 8.150 8,900 -
29 Dec 2020 7.890 8.000 7.540 7.910 58,115 -
28 Dec 2020 7.930 7.990 7.345 7.391 17,976 -
24 Dec 2020 7.610 7.910 7.610 7.730 5,733 -
23 Dec 2020 7.990 8.010 7.710 7.710 17,702 -
22 Dec 2020 8.000 8.150 8.000 8.150 9,771 -
21 Dec 2020 8.010 8.220 7.960 8.000 3,281 -
18 Dec 2020 8.200 8.400 8.155 8.300 4,473 -
Summary
Current 2 Weeks
(07 Jan 2021 to 21 Jan 2021)
9.010 9.263 7.940 8.480 220,346 -
Previous 2 Weeks
(22 Dec 2020 to 06 Jan 2021)
8.000 9.263 7.940 8.590 161,470 -
4 Weeks from
(23 Nov 2020 to 21 Dec 2020)
9.179 9.263 7.940 8.000 226,031 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.